We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




ZyGEM to Commercialize DNA Detection and Testing Platform

By LabMedica International staff writers
Posted on 07 Jun 2010
ZyGEM Corp. More...
Ltd. (Hamilton, New Zealand; and Solana Beach, CA, USA) has acquired MicroLab Diagnostics Inc., a private company developing microfluidic devices for rapid DNA testing. ZyGEM will market products integrating its DNA extraction, reagents, and detection assays with microfluidic chip technology developed by MicroLab, which will operate as a business unit of the new company.

MicroLab's miniaturization of the entire DNA testing process within a single closed system significantly reduces the amount of sample and reagents that are needed, while virtually eliminating the chances for handling error or contamination. The integrated new products will dramatically decrease the time, complexity, and cost of conducting DNA testing and have transformational potential in a broad range of applications.

The ZyGEM/MicroLab system is compact, easy-to-use, and cost-effective, making it suitable for use both in the laboratory and out in the field. It can perform multiplexed analyses, and it can also be configured for specific applications. Portable handheld versions are in development.

A prototype of the new system produced accurate DNA results in less than an hour, comparable to results obtained with current technology requiring three separate instruments and 5 to 10 hours. The new technology has the potential for applications where accuracy, speed, and ease-of-use are critical, including, point-of-care diagnostics, forensics, biodefense, and food pathogen testing.

ZyGEM intends to continue to expand sales of its proprietary assays and kits that use a thermophilic enzyme to extract DNA or RNA from a wide range of sample types using a single, closed-tube system.

Under the terms of the agreement, the new company will be called ZyGEM and will be headquartered in Charlottesville, Virginia (USA).

Dr. James Landers, cofounder of MicroLab Diagnostics and CSO of the new company, noted, "ZyGEM brings us DNA extraction and detection technology that is an ideal fit with our microchips, enabling us to achieve a seamless sample-to-answer solution with broad market applicability. It also brings us commercial expertise and a global network of distributors and partners.

Related Links:

ZyGEM Corp. Ltd.
MicroLab Diagnostics Inc.



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.